Skip to content

Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum: Evaluation of Clinical Practices in Five Maternity Hospitals in Île-de-France

Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum: Evaluation of Clinical Practices in Five Maternity Hospitals in Île-de-France

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06841029
Enrollment
117
Registered
2025-02-21
Start date
2023-10-15
Completion date
2024-03-15
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

He Study Focuses on Evaluating Current Clinical Practices Rather Than Testing an Intervention

Keywords

NVP, hyperemesis gravidarum, clinical practices, adequacy, recommendations,CNGOF

Brief summary

This clinical trial aims to evaluate the adequacy of healthcare professionals' clinical practices regarding nausea and vomiting in pregnancy (NVP) and hyperemesis gravidarum (HG) with the recommendations of the National College of French Obstetricians and Gynecologists (CNGOF). The study involves 117 participants and follows an observational, cross-sectional, multicenter study design conducted in five maternity hospitals in Île-de-France.

Interventions

None listed

Sponsors

Centre Hospitalier de Saint-Denis
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Midwives, obstetrician-gynecologists, and gynecology-obstetrics interns working in the labor and delivery units, high-risk pregnancy units, and obstetric-gynecological emergency units of the five selected maternity hospitals.

Exclusion criteria

* Midwives or doctors in training (student midwives or medical externs) * Midwives and obstetrician-gynecologists working in private practice

Design outcomes

Primary

MeasureTime frame
Percentage of healthcare professionals whose management of NVP and HG aligns with CNGOF recommendations.data collection period: October 2023-March 2024

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026